Ultragenyx Granted Additional Orphan Drug Designations for Triheptanoin – MarketWatch
Ultragenyx Granted Additional Orphan Drug Designations for TriheptanoinMarketWatchUltragenyx is conducting a Phase 2 study in the U.S. And Europe to evaluate the potential of triheptanoin to treat Glut1 DS patients who are not on or who have failed the ketogenic diet and continue to have seizures. Ultragenyx intends to initiate a …and more »
[monetize id=”1″]
[monetize id=”2″]
Mike Dancer on Healing Epilepsy with the Ketogenic Diet no …
The Cult of Biohacking – Outside Magazine
Outside MagazineThe Cult of BiohackingOutside MagazineIn 2008, after hearing that lithium carbonate may help treat ALS, some individuals who suffered from the disease began taking the substance to see whether it had any effect. They uploaded their findings to a website, and a neuropsychologist crunched …and more »
